Evommune, Inc.
EVMN
$14.65
$0.584.12%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -46.17% | 3.30% | -3.09% | -- | -- |
| Total Depreciation and Amortization | 6.58% | -2.30% | 7.93% | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 221.35% | -889.25% | -4,839.80% | -- | -- |
| Change in Net Operating Assets | 138.07% | -682.25% | -155.48% | -- | -- |
| Cash from Operations | 21.82% | -3.60% | -31.35% | -- | -- |
| Capital Expenditure | -- | -1,666.67% | -167.05% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,658.36% | -173,760.16% | -2,846.79% | -- | -- |
| Cash from Investing | -2,664.76% | -151,790.78% | -2,787.73% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 19.75% | 9.90% | -25.53% | -- | -- |
| Issuance of Common Stock | 1,618,464.71% | 2,111,330.77% | 1,209,823.08% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -100.00% | 30.90% | 30.90% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.00% | -- | -- | -- | -- |
| Cash from Financing | 141.01% | 585.28% | 346.72% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -103.02% | 256.05% | 327.23% | -- | -- |